Our group and others described cases of patients with progressive NSCLC under TKI treatment with evidence of sharp elevation of AF of EGFR activating mutation in ctDNA measured with ddPCR, concurrent with evidence of histologic transformation to SCLC [64,65,66]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.